Editorial: vedolizumab in pregnancy - is gut selectivity as good for baby as it is for mum? Authors' reply

Aliment Pharmacol Ther. 2017 May;45(9):1284. doi: 10.1111/apt.14054.

Authors

U Mahadevan¹, S Vermeire², K Lasch³, B Abhyankar⁴, F Bhayat⁴, A Blake⁴, M Dubinsky⁵

Affiliations

¹ Center for Colitis and Crohn's Disease, University of California San Francisco, San Francisco, CA, USA.
² University Hospital Gasthuisberg, Leuven, Belgium.
³ Takeda Pharmaceuticals USA, Inc., Deerfield, IL, USA.
⁴ Takeda Development Centre Europe Ltd, London, UK.
⁵ Department of Pediatrics, Susan and Leonard Feinstein IBD Clinical Center, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

PMID: 28370036
DOI: 10.1111/apt.14054

No abstract available

Publication types

Editorial
Comment

MeSH terms

Antibodies, Monoclonal, Humanized*
Colitis, Ulcerative*
Female
Humans
Pregnancy

Substances

Antibodies, Monoclonal, Humanized
vedolizumab